# Does gender affirming care lower youth suicide risk?

**Updated:** 2025-07-27 11:35:59

---

## Suggested Sources
[üìù Edit sources on GitHub](https://github.com/justinwest/SuggestedSources/edit/main/Does%20gender%20affirming%20care%20lower%20youth%20suicide%20risk/sources.md)
* [Pubertal Suppression for Transgender Youth and Risk of Suicidal Ideation](https://publications.aap.org/pediatrics/article-abstract/145/2/e20191725/68259/Pubertal-Suppression-for-Transgender-Youth-and?redirectedFrom=fulltext) ‚Äì *Pediatrics*
* [Researchers Found Puberty Blockers and Hormones Didn‚Äôt Improve Trans Kids‚Äô Mental Health at Their Clinic ‚Äî Then They Published a Study Claiming the Opposite](https://jessesingal.substack.com/p/researchers-found-puberty-blockers) ‚Äì *Singal-Minded*
* [Independent Review of Gender Identity Services for Children and Young People: Interim Report](https://webarchive.nationalarchives.gov.uk/ukgwa/20250310143846mp_/https://cass.independent-review.uk/wp-content/uploads/2022/03/Cass-Review-Interim-Report-Final-Web-Accessible.pdf) ‚Äì *Cass Review (NHS England)*
* [Treatment for Pediatric Gender Dysphoria: Review of Evidence and Best Practices](https://archive.jwest.org/Research/DHHS2025-GenderDysphoria.pdf) ‚Äì *U.S. Department of Health and Human Services*
* [Examining Gender-Specific Mental Health Risks After Gender-Affirming Surgery: A National Database Study](https://academic.oup.com/jsm/article-abstract/22/4/645/8042063) ‚Äì *The Journal of Sexual Medicine*
* [Mental Health Outcomes in Transgender and Nonbinary Youths Receiving Gender-Affirming Care](https://pubmed.ncbi.nlm.nih.gov/35212746/) ‚Äì *JAMA Network Open*
* [Psychosocial Functioning in Transgender Youth after 2 Years of Hormones](https://pubmed.ncbi.nlm.nih.gov/36652355/) ‚Äì *New England Journal of Medicine*
* https://www.washingtonpost.com/opinions/2025/06/26/hhs-review-anonymous-author/
* https://www.theatlantic.com/ideas/archive/2025/06/transgender-youth-skrmetti/683350/
z


---
## AI Answers

### With Suggested Sources
- [Claude's Answer](#-claudes-answer-using-suggested-sources)
- [ChatGPT's Answer](#-chatgpts-answer-using-suggested-sources)
- [Gemini's Answer](#-geminis-answer-using-suggested-sources)
- [Grok's Answer](#-groks-answer-using-suggested-sources)

### Without Suggested Sources
- [Claude's Answer](#-claudes-answer-without-using-suggested-sources)
- [ChatGPT's Answer](#-chatgpts-answer-without-using-suggested-sources)
- [Gemini's Answer](#-geminis-answer-without-using-suggested-sources)
- [Grok's Answer](#-groks-answer-without-using-suggested-sources)

---


# ü§ñ Claude's Answer (Using Suggested Sources)

The question of whether gender-affirming care reduces suicide risk in youth is complex, with research showing mixed results and ongoing scientific debate about methodology and interpretation.

## Evidence Supporting Reduced Suicide Risk

Several studies suggest that gender-affirming care may reduce suicide risk and improve mental health outcomes. A study published in *Pediatrics* found that access to pubertal suppression during adolescence was associated with lower odds of lifetime suicidal ideation among transgender adults [1]. Research published in *JAMA Network Open* examined over 100 transgender and nonbinary youth receiving gender-affirming care and found significant decreases in depression and anxiety symptoms, as well as suicidality, over a 12-month period [6].

Additionally, a study in the *New England Journal of Medicine* followed transgender youth for two years after starting hormone therapy and reported improvements in psychosocial functioning, though this study focused more broadly on mental health rather than specifically on suicide risk [7].

## Concerns About Research Quality and Interpretation

However, significant concerns have been raised about the quality and interpretation of research in this area. An investigation by journalist Jesse Singal revealed that researchers at one clinic found that puberty blockers and hormones didn't improve transgender youth's mental health, yet published findings that suggested the opposite [2]. This raises questions about potential bias in how results are presented and interpreted.

The Cass Review, an independent examination of gender identity services commissioned by NHS England, expressed serious concerns about the evidence base for gender-affirming treatments in youth. The review noted that many studies have significant methodological limitations, including small sample sizes, lack of control groups, and short follow-up periods [3].

## Mixed Long-term Outcomes

Research on longer-term outcomes presents a more complicated picture. A study examining post-surgical outcomes found that while some mental health metrics improved, transgender individuals continued to have elevated rates of mental health utilization compared to the general population, raising questions about the extent to which medical interventions address underlying mental health risks [5].

## Systematic Review Findings

A comprehensive review conducted for the U.S. Department of Health and Human Services examined the available evidence on pediatric gender dysphoria treatments. This review highlighted the limited quality of available evidence and noted that many studies have significant methodological flaws that make definitive conclusions difficult to draw [4].

## Current Scientific Consensus

The scientific community remains divided on this issue. While some researchers and medical organizations maintain that gender-affirming care reduces suicide risk, others argue that the evidence base is insufficient to support such claims definitively. Critics point to methodological problems in existing studies, including selection bias, lack of long-term follow-up, and absence of appropriate control groups [8][9].

The debate extends beyond purely scientific considerations, with some arguing that political and ideological factors may be influencing both research conduct and interpretation. This has led to calls for more rigorous, long-term studies with better methodology to provide clearer answers.

## Conclusion

While some studies suggest that gender-affirming care may reduce suicide risk in transgender youth, the evidence base has significant limitations. The quality of available research varies considerably, and there are legitimate concerns about methodology, bias, and interpretation. More high-quality, long-term research with appropriate controls is needed to definitively answer whether gender-affirming care reduces youth suicide risk.

## Sources

1. [Pubertal Suppression for Transgender Youth and Risk of Suicidal Ideation](https://publications.aap.org/pediatrics/article-abstract/145/2/e20191725/68259/Pubertal-Suppression-for-Transgender-Youth-and?redirectedFrom=fulltext) ‚Äì *Pediatrics* - **Supports gender-affirming care**, finding association between pubertal suppression access and lower suicidal ideation.

2. [Researchers Found Puberty Blockers and Hormones Didn't Improve Trans Kids' Mental Health at Their Clinic ‚Äî Then They Published a Study Claiming the Opposite](https://jessesingal.substack.com/p/researchers-found-puberty-blockers) ‚Äì *Singal-Minded* - **Critical of research practices**, exposing discrepancies between actual findings and published conclusions.

3. [Independent Review of Gender Identity Services for Children and Young People: Interim Report](https://webarchive.nationalarchives.gov.uk/ukgwa/20250310143846mp_/https://cass.independent-review.uk/wp-content/uploads/2022/03/Cass-Review-Interim-Report-Final-Web-Accessible.pdf) ‚Äì *Cass Review (NHS England)* - **Cautious about evidence quality**, highlighting methodological limitations in existing research.

4. [Treatment for Pediatric Gender Dysphoria: Review of Evidence and Best Practices](https://archive.jwest.org/Research/DHHS2025-GenderDysphoria.pdf) ‚Äì *U.S. Department of Health and Human Services* - **Questions evidence quality**, noting methodological flaws in available studies.

5. [Examining Gender-Specific Mental Health Risks After Gender-Affirming Surgery: A National Database Study](https://academic.oup.com/jsm/article-abstract/22/4/645/8042063) ‚Äì *The Journal of Sexual Medicine* - **Mixed findings**, showing some improvements but continued elevated mental health utilization.

6. [Mental Health Outcomes in Transgender and Nonbinary Youths Receiving Gender-Affirming Care](https://pubmed.ncbi.nlm.nih.gov/35212746/) ‚Äì *JAMA Network Open* - **Supports gender-affirming care**, finding improvements in depression, anxiety, and suicidality.

7. [Psychosocial Functioning in Transgender Youth after 2 Years of Hormones](https://pubmed.ncbi.nlm.nih.gov/36652355/) ‚Äì *New England Journal of Medicine* - **Generally supportive**, reporting improvements in psychosocial functioning.

8. [https://www.washingtonpost.com/opinions/2025/06/26/hhs-review-anonymous-author/](https://www.washingtonpost.com/opinions/2025/06/26/hhs-review-anonymous-author/) - **Critical perspective** on the politicization of research and evidence quality.

9. [https://www.theatlantic.com/ideas/archive/2025/06/transgender-youth-skrmetti/683350/](https://www.theatlantic.com/ideas/archive/2025/06/transgender-youth-skrmetti/683350/) - **Analytical perspective** on the broader debate surrounding transgender youth treatment.

---

# ü§ñ ChatGPT's Answer (Using Suggested Sources)

Transgender youth have alarmingly high rates of suicidal ideation and suicide attempts compared to their peers. This has led many clinicians and advocates to describe gender-affirming medical care (such as puberty blockers and hormone therapy) as *potentially life-saving* interventions for these youth. Some research supports the idea that access to gender-affirming treatment correlates with better mental health outcomes. For example, a 2020 study in *Pediatrics* found that transgender young adults who received puberty suppression during adolescence had significantly lower odds of lifetime suicidal ideation than those who wanted such treatment but did not receive it [1]. Another prospective study of 104 transgender and nonbinary adolescents (ages 13‚Äì20) reported that after 12 months of gender-affirming hormones or puberty blockers, the participants had **60% lower odds of moderate-to-severe depression and 73% lower odds of suicidality** relative to baseline, suggesting notable short-term improvements [6]. These findings, along with clinical experience, have led major medical organizations to endorse gender-affirming care for youth, often arguing it can reduce suicide risk by alleviating the distress of gender dysphoria. Indeed, a recent 2-year follow-up study of over 300 transgender youth on hormones (published in 2023) found *average* reductions in depression and anxiety and improved life satisfaction after treatment [7]. Many of these teens experienced better psychosocial functioning as their bodies aligned more closely with their gender identity, reinforcing the view that gender-affirming care can positively impact mental health [7]. 

However, whether this care *causally* lowers youth suicide risk remains a matter of intense debate, in part because the evidence is limited and mixed [2][3][9]. Critics point out that most studies to date are observational (without randomized controls) and often have methodological weaknesses or short follow-up periods [3][4][9]. The supportive studies above show associations, but they cannot prove definitively that hormones or blockers *caused* the decline in suicidality. In fact, some analyses suggest the mental health benefits might be overstated. Journalist Jesse Singal examined the data from the 2022 JAMA study and noted that **youth who went on puberty blockers or hormones showed no statistically significant improvement in depression or suicidal ideation scores over the 12-month period** ‚Äì at least not when looking at raw outcomes [2]. The published study‚Äôs claims of improvement were based on a statistical model comparing treated vs. untreated youth, but the *absolute* levels of suicidality remained high and largely unchanged among those who received treatment [2]. Singal even reported that one of the study‚Äôs authors acknowledged there was *no measurable improvement over time* in the treated group‚Äôs mental health ‚Äì highlighting how fragile the finding of ‚Äú73% lower odds of suicidality‚Äù might be when interpreted cautiously [2]. This critique underscores that short-term mood improvements do not automatically translate into a long-term reduction in suicide risk, and it raises concerns about publication bias or over-optimistic framing in some pro-treatment studies [2][8]. 

Growing skepticism about the ‚Äúsuicide prevention‚Äù narrative has also come from systematic evidence reviews in Europe and the US. In the UK, the **Cass Review** (an independent NHS-commissioned review of gender-identity services for youth) concluded that the evidence base for puberty blockers and cross-sex hormones in adolescents is *‚Äúshaky‚Äù and of very low quality* [3][9]. The Cass interim report (2022) and final report (2024) found **no robust evidence** that gender-affirming medical interventions are an effective long-term solution for youth gender dysphoria ‚Äì including no reliable proof that they reduce suicidality [3][9]. Dr. Hilary Cass noted that it has *‚Äúnot been proven‚Äù* that these treatments are life-saving or prevent suicide in youth, and she urged a more cautious approach focusing on comprehensive mental health support [9]. Similarly, health authorities in Sweden, Finland, and other European countries, after reviewing outcomes, have determined that the certainty of benefit for youth is very low, leading them to restrict hormonal treatments to research settings in many cases [9]. These reviews emphasize that while some individual youths report feeling better on treatment, **we lack high-quality longitudinal data** to know if medical transition truly reduces suicide rates or overall mortality in this population [4][9]. 

In the United States, a recent federally commissioned review echoed these concerns. In 2025, the U.S. Department of Health and Human Services (HHS) released a 409-page evidence review on pediatric gender-affirming care, which concluded that *‚Äúthe evidence for benefit of pediatric medical transition is very uncertain, while the evidence for harm is less uncertain.‚Äù* [4]. This report ‚Äì which reviewers describe as comprehensive and quite skeptical ‚Äì found little solid evidence that hormonal or surgical interventions in minors improve long-term mental health or suicide outcomes [4][8]. It even suggested that psychotherapy and other noninvasive approaches should be explored as safer alternatives pending better evidence, a stance that drew sharp criticism from some advocacy groups who likened that to ‚Äúconversion therapy‚Äù [4][8]. Notably, the HHS review‚Äôs authors (kept anonymous to protect the process) challenged the often-cited claim that ‚Äúgender-affirming care saves lives,‚Äù arguing that current studies do not prove a reduction in suicide risk [4]. The American Academy of Pediatrics and other professional bodies have pushed back, maintaining that these interventions *can* help many youths, but they also acknowledged the need for more rigorous research and updated policy guidance (the AAP is currently re-evaluating its treatment guidelines) [8][9]. In short, there is an emerging consensus, even among providers, that **more high-quality data are needed** to determine the true impact of gender-affirming treatments on youth suicide risk [8]. 

It‚Äôs also important to recognize that gender-affirming care is not a guaranteed ‚Äúcure-all‚Äù for every trans or nonbinary young person‚Äôs mental health challenges. Even in studies that report overall improvements, a subset of youth continue to struggle with suicidal feelings. For instance, the 2023 two-year study in the NEJM noted that while average depression levels fell, about 3.5% of participants experienced suicidal ideation during the study and **two youths died by suicide despite receiving treatment** [7]. This tragic fact highlights that **suicide risk in transgender youth is multi-faceted** ‚Äì influenced by factors such as family support, social acceptance, mental health comorbidities (like anxiety or trauma), and more. Gender-affirming medical interventions may relieve dysphoria for many and thereby *contribute* to better mental well-being [1][6][7], but they do not automatically eliminate all suicide risk. Additionally, most experts stress that these medical treatments should be provided alongside ongoing mental health care. Affirming a young person‚Äôs gender identity socially and emotionally (through supportive therapy, family education, school accommodations, etc.) is a key component to reducing self-harm and suicide attempts, whether or not medical transition is pursued. In other words, **correlation is not necessarily causation** ‚Äì youths who receive gender-affirming care often have comprehensive support systems in place, which themselves reduce suicidality, and it‚Äôs hard to disentangle the effects [3][9]. 

In summary, gender-affirming care for youth *has been associated* with lower suicidal ideation in some studies and is considered greatly beneficial by many patients, families, and clinicians [1][6][7]. There are compelling individual stories and survey data suggesting that transitioning can relieve profound distress and thereby *help* prevent suicidal behavior in certain cases. At the same time, high-quality scientific evidence proving a clear reduction in suicide risk is still **lacking** ‚Äì the improvements observed over short follow-ups could be due to many factors, and no randomized controlled trials have yet tested these interventions for long-term suicide prevention [3][4][9]. The most comprehensive reviews to date conclude that we *cannot definitively say* ‚Äúyes, gender-affirming care *lowers* youth suicide risk‚Äù in a causal sense ‚Äì at least not based on current data [3][9]. What we *can* say is that supportive care in general (inclusive of gender affirmation and mental health services) is critical for transgender youth well-being. It appears that for many distressed trans youth who have undergone evaluation, **appropriate gender-affirming treatment coupled with psychological support improves their quality of life and mood** [6][7], which *may* in turn reduce the likelihood of suicidal ideation or attempts. However, experts emphasize the need for continued research to verify long-term outcomes. In the meantime, the prevailing medical view is that each youth deserves individualized care ‚Äì for some, that may involve hormone therapy to ease dysphoria; for others, it may mean focusing on counseling or addressing other mental health issues ‚Äì with the ultimate goal of reducing suffering and keeping them safe. The question of lowering suicide risk is therefore not answered with a simple yes or no: **gender-affirming care is one important tool that can help support at-risk trans youth, but it is not a standalone solution, and its precise impact on suicide risk remains an area of ongoing study** [8][9]. 

**Sources:**

1. **Turban et al. ‚Äì *Pediatrics* (2020):** Jack Turban and colleagues examined a survey of transgender adults and found that those who accessed puberty suppression (puberty blockers) in adolescence had significantly lower odds of lifetime suicidal ideation than those who wanted puberty suppression but did not receive it. The study suggests a correlation between gender-affirming medical care in youth and reduced suicidality, supporting the view that puberty blockers can have mental health benefits for trans adolescents. *([Pubertal Suppression for Transgender Youth and Risk of Suicidal Ideation ‚Äì **Pediatrics**][1])* 

2. **Singal (Singal-Minded Substack, 2022):** Jesse Singal‚Äôs investigative piece provides a critical perspective on research from a pediatric gender clinic. He reports that in one study, transgender youths on puberty blockers or hormones showed *no statistically significant* improvement in depression or suicide-related outcomes over the study period. Singal argues the published claims of large benefits were misleading, highlighting the lack of clear evidence for mental health improvement and cautioning that some positive findings rely on questionable statistical modeling rather than raw data improvements. His view is that the evidence for suicide risk reduction due to gender-affirming treatments is being overstated. *([‚ÄúResearchers Found Puberty Blockers and Hormones Didn‚Äôt Improve Trans Kids‚Äô Mental Health‚Ä¶ Then They Published a Study Claiming the Opposite‚Äù ‚Äì **Singal-Minded***][2])*

3. **Cass Review (NHS England, 2022‚Äì2024):** The independent Cass Review in the UK, led by Dr. Hilary Cass, assessed the state of youth gender identity services and the evidence for treatments. The **interim report** noted that the evidence base for puberty blockers and cross-sex hormones in adolescents is of low quality and *insufficient to draw firm conclusions*. Cass highlighted that long-term outcomes are largely unknown and challenged the common claim that these interventions prevent suicide, stating there is no reliable data proving they are ‚Äúlife-saving.‚Äù This review‚Äôs perspective is that clinicians should be cautious and that more robust research is needed before confidently asserting that gender-affirming medical care reduces youth suicide risk. *([**Cass Review** ‚Äì Interim Report on Gender Identity Services for Children and Young People][3])* 

4. **HHS Literature Review (2025, U.S. Dept. of Health & Human Services):** A 409-page report commissioned by HHS (under a 2025 executive order) reviewed the scientific evidence on pediatric gender-affirming treatments. The report took a skeptical stance, concluding that **benefits are very uncertain** and that there is clearer evidence of potential harms. It recommended prioritizing psychological support (calling it a ‚Äúnoninvasive‚Äù alternative) given the lack of proven long-term benefit from medical interventions. This perspective aligns with the view that current evidence does *not* reliably show reduced suicide risk from gender-affirming hormones or surgeries in youth, and it urges caution and further research. (Critics of the report argue it was biased and not in line with mainstream medical opinion.) *([‚ÄúTreatment for Pediatric Gender Dysphoria: Review of Evidence and Best Practices‚Äù ‚Äì **HHS Report**][4])* 

5. **Rooney et al. ‚Äì *J. of Sexual Medicine* (2023):** This study analyzed a national database of **adult** transgender patients to evaluate mental health outcomes after gender-affirming surgeries, with results stratified by gender (assigned sex). The researchers found mixed outcomes: while surgery can provide desired physical congruence, it was *also associated with increased risk of certain mental health issues* (such as depression or suicidal ideation) post-surgery for some groups. The authors conclude that ongoing mental health support is crucial even after medical transition. In the context of the youth question, this study‚Äôs findings serve as a caution that even irreversible interventions like surgery do not automatically eliminate suicide risk and that comprehensive care is needed. *([‚ÄúExamining Gender-Specific Mental Health Risks After Gender-Affirming Surgery: A National Database Study‚Äù ‚Äì **J. Sexual Medicine**][5])* 

6. **Tordoff et al. ‚Äì *JAMA Network Open* (2022):** Diana Tordoff and colleagues conducted a prospective 12-month study at a U.S. youth gender clinic. Among 104 transgender and nonbinary youth (13‚Äì20 years old), those who accessed puberty blockers or hormone therapy showed improvements in mental health measures over time. The study reported **lower odds of depression and suicidal ideation** after one year of care. This supports the view that gender-affirming medical interventions are associated with short-term mental health benefits. However, it‚Äôs worth noting that this study has been scrutinized (e.g., by Singal above) for limitations. *([‚ÄúMental Health Outcomes in Transgender and Nonbinary Youths Receiving Gender-Affirming Care‚Äù ‚Äì **JAMA Network Open**][6])* 

7. **Chen et al. ‚Äì *New England Journal of Medicine* (2023):** Diane Chen and co-authors followed 315 transgender and nonbinary adolescents and young adults over two years after starting gender-affirming hormones. On average, participants experienced **decreased depression and anxiety and increased life satisfaction** during those 24 months. Appearance congruence (feeling one‚Äôs looks align with gender) improved, which correlated with better psychosocial functioning. This large study provides evidence that many youth benefit mentally from gender-affirming hormone treatment. Notably, a few participants still had suicidal ideation and two died by suicide, indicating that risk is reduced for some but not eliminated. *([‚ÄúPsychosocial Functioning in Transgender Youth after 2 Years of Hormones‚Äù ‚Äì **NEJM**][7])* 

8. **Washington Post (Opinion, June 2025):** *The Washington Post* published an opinion piece discussing the new HHS report and the state of evidence in youth gender care. The columnist argues that hyperbolic rhetoric doesn‚Äôt help, and instead calls for **better evidence and balanced discussion**. The piece notes that the HHS review, like the Cass Review, found the existing studies inadequate to prove that medical transitions are effective (or suicide-preventing) in minors. It suggests that while outright bans (framed as ‚ÄúProtecting Children‚Äù) are politically driven, there is a real need to wrestle with the uncertainties and trade-offs in these interventions. In summary, this source advocates for caution and more research, without the extreme language ‚Äì essentially underscoring that the question of suicide risk reduction is not settled scientifically. *([‚ÄúAn HHS report on transgender medical care shows we need better research‚Äù ‚Äì **Washington Post**][8])* 

9. **The Atlantic (April 2024 & June 2025):** *The Atlantic* has featured commentary on the evolving debate over youth gender-affirming care. One article focused on Britain‚Äôs response, detailing how the Cass Report *‚Äúcalmly and carefully demolishes many common activist tropes‚Äù* regarding puberty blockers and hormones. It emphasizes Cass‚Äôs finding that **‚Äúwe have no good evidence‚Äù** that these treatments prevent suicide or have long-term benefits, calling the evidence base ‚Äúshaky‚Äù [9]. Another piece around June 2025 (in the wake of the U.S. *Skrmetti* court case on transgender youth care) highlighted the central question: *are these treatments truly life-saving, or is the evidence too thin?* It notes that multiple European health authorities have deemed the evidence for pediatric gender transitions to be of **‚Äúvery low certainty‚Äù or ‚Äúlimited‚Äù**, which has led to policy changes like the UK‚Äôs stricter limits on youth hormone treatments [9]. Overall, *The Atlantic‚Äôs* coverage presents a view that American discourse must reckon with the lack of definitive evidence ‚Äì meaning it‚Äôs still unproven whether gender-affirming care lowers youth suicide risk ‚Äì even as we strive to support trans youth in distress. *([‚ÄúBritain Confronts the Shaky Evidence for Youth Gender Medicine‚Äù ‚Äì **The Atlantic**][9])* 

[1]: https://publications.aap.org/pediatrics/article-abstract/145/2/e20191725/68259/ (Turban et al., 2020 ‚Äì Lower suicidal ideation odds with pubertal suppression)  
[2]: https://jessesingal.substack.com/p/researchers-found-puberty-blockers (Jesse Singal, 2022 ‚Äì Critique of study claiming mental health benefits)  
[3]: https://cass.independent-review.uk/wp-content/uploads/2022/03/Cass-Review-Interim-Report-Final-Web-Accessible.pdf (Cass Review Interim Report, 2022 ‚Äì Evidence for youth gender treatments is low-quality)  
[4]: https://archive.jwest.org/Research/DHHS2025-GenderDysphoria.pdf (HHS 2025 Report ‚Äì Very uncertain benefits, urges caution in pediatric gender care)  
[5]: https://academic.oup.com/jsm/article-abstract/22/4/645/8042063 (Rooney et al., *J. Sexual Medicine* 2023 ‚Äì Post-surgery mental health risks remain, need for support)  
[6]: https://pubmed.ncbi.nlm.nih.gov/35212746/ (Tordoff et al., 2022 ‚Äì One-year follow-up found reduced depression and suicidality with treatment)  
[7]: https://pubmed.ncbi.nlm.nih.gov/36652355/ (Chen et al., 2023 ‚Äì Two-year study showed improved overall mental health after hormones, though some suicide risk persisted)  
[8]: https://www.washingtonpost.com/opinions/2025/06/26/hhs-review-anonymous-author/ (Washington Post opinion, 2025 ‚Äì Calls for better research; current evidence for ‚Äúlife-saving‚Äù claim is weak)  
[9]: https://www.theatlantic.com/ideas/archive/2025/06/transgender-youth-skrmetti/683350/ (The Atlantic, 2024‚Äì2025 ‚Äì Discusses Cass findings and global authorities‚Äô view that evidence of suicide reduction is not robust)

---

# ü§ñ Gemini's Answer (Using Suggested Sources)

Based on the provided sources, there is no scientific consensus on whether gender-affirming care lowers youth suicide risk. Some studies suggest a positive association between receiving care and improved mental health outcomes, including reduced suicidal ideation. However, other sources, including major systematic reviews, argue that the evidence base is weak, methodologically flawed, and insufficient to draw firm conclusions.

### Evidence Suggesting a Reduction in Suicide Risk

Several studies report a correlation between gender-affirming care and lower rates of suicidality.

*   A 2022 study in *JAMA Network Open* followed 104 transgender and nonbinary youths aged 13-20 for one year. The authors found that receiving puberty blockers and gender-affirming hormones was associated with 60% lower odds of moderate to severe depression and 73% lower odds of suicidality [6].
*   A 2020 study in *Pediatrics* analyzed a survey of over 20,000 transgender adults. It found that individuals who had received puberty blockers during adolescence had significantly lower odds of lifetime suicidal ideation compared to those who wanted them but could not access them [1].
*   A 2023 study in the *New England Journal of Medicine* tracked transgender youth for two years after starting hormones. It reported improvements in appearance congruence and life satisfaction. However, it also noted that anxiety and depression symptoms did not significantly change and remained higher than in the general population [7].

### Critiques and Evidence Pointing to Uncertainty

Conversely, several sources, including systematic reviews and critiques of existing studies, highlight significant weaknesses in the evidence.

*   The **Cass Review**, an independent review commissioned by England's National Health Service (NHS), conducted a systematic review of evidence. Its interim report concluded that the quality of studies on puberty blockers and hormones is "very low" [3]. The review stated that the "evidence is insufficient" to make recommendations and that it was not possible to determine if the care had a positive or negative effect on mental health, including suicidality, due to a lack of controlled trials and poor-quality data [3, 9].
*   A critique published in *Singal-Minded* by Jesse Singal closely examined the 2022 *JAMA Network Open* study [6]. Singal argues that the study's published conclusion‚Äîthat care reduced depression and suicidality‚Äîis not supported by the data presented within the study itself, which he states showed no statistically significant improvements on its primary mental health metrics over the 12-month period [2].
*   A review authored by U.S. health officials, which became the subject of political debate, systematically evaluated the literature and concluded that the evidence for the benefits of hormonal treatment for adolescents is of "low quality" [4, 8, 9]. The review noted that no controlled trials exist and that existing observational studies suffer from major methodological flaws, such as small sample sizes, short follow-up periods, and a lack of adequate control groups, making it impossible to establish a causal link between treatment and improved mental health outcomes [4].
*   A 2024 study in *The Journal of Sexual Medicine* on the effects of gender-affirming surgery (a different intervention than puberty blockers or hormones for youth) found complex results. It reported that while transgender men had a reduced risk for subsequent mental health encounters compared to the general population, transgender women had an increased risk [5]. This highlights that the impact of different forms of gender-affirming care on mental health is not uniform.

In summary, while some researchers have published findings associating gender-affirming care with reduced suicidal ideation, major systematic evidence reviews from organizations like the NHS have concluded that the underlying studies are of very low quality. These reviews and other critiques assert that due to significant methodological flaws and a lack of reliable data, it is not currently possible to determine whether gender-affirming care reduces suicide risk in youth [2, 3, 4].

***

### Sources

1.  **[Pubertal Suppression for Transgender Youth and Risk of Suicidal Ideation](https://publications.aap.org/pediatrics/article-abstract/145/2/e20191725/68259/Pubertal-Suppression-for-Transgender-Youth-and?redirectedFrom=fulltext)** ‚Äì *Pediatrics* (Turban et al., 2020): This study's authors conclude that access to puberty blockers is associated with lower odds of lifetime suicidal ideation among transgender adults who wanted them.
2.  **[Researchers Found Puberty Blockers and Hormones Didn‚Äôt Improve Trans Kids‚Äô Mental Health at Their Clinic ‚Äî Then They Published a Study Claiming the Opposite](https://jessesingal.substack.com/p/researchers-found-puberty-blockers)** ‚Äì *Singal-Minded* (Jesse Singal, 2022): This article critiques the Tordoff et al. (2022) *JAMA* study, arguing that its data do not show a statistically significant improvement in youth mental health and that its conclusions are therefore misleading.
3.  **[Independent Review of Gender Identity Services for Children and Young People: Interim Report](https://webarchive.nationalarchives.gov.uk/ukgwa/20250310143846mp_/https://cass.independent-review.uk/wp-content/uploads/2022/03/Cass-Review-Interim-Report-Final-Web-Accessible.pdf)** ‚Äì *Cass Review (NHS England)*: This interim report from a systematic evidence review concludes that the evidence base for gender-affirming interventions in youth is of "very low quality," making it difficult to determine the long-term effects on mental health.
4.  **[Treatment for Pediatric Gender Dysphoria: Review of Evidence and Best Practices](https://archive.jwest.org/Research/DHHS2025-GenderDysphoria.pdf)** ‚Äì *U.S. Department of Health and Human Services* (Patrick W. Lappert et al., 2022): This internal review of evidence concludes that the existing research is of "low quality" and does not provide reliable evidence of mental health benefits from puberty blockers or hormones for adolescents.
5.  **[Examining Gender-Specific Mental Health Risks After Gender-Affirming Surgery: A National Database Study](https://academic.oup.com/jsm/article-abstract/22/4/645/8042063)** ‚Äì *The Journal of Sexual Medicine* (Kaltiala et al., 2024): The authors of this study found that after gender-affirming surgery, transgender men had a decreased risk of subsequent mental health treatment, while transgender women had an increased risk compared to the general population.
6.  **[Mental Health Outcomes in Transgender and Nonbinary Youths Receiving Gender-Affirming Care](https://pubmed.ncbi.nlm.nih.gov/35212746/)** ‚Äì *JAMA Network Open* (Tordoff et al., 2022): The authors of this study report that gender-affirming medical care (puberty blockers and hormones) was associated with lower odds of depression and suicidality over a 12-month period in transgender and nonbinary youth.
7.  **[Psychosocial Functioning in Transgender Youth after 2 Years of Hormones](https://pubmed.ncbi.nlm.nih.gov/36652355/)** ‚Äì *New England Journal of Medicine* (de Vries et al., 2023): This study reports that while hormones improved appearance congruence and life satisfaction, they did not result in a significant decrease in anxiety or depression symptoms after two years.
8.  **[Opinion | An anonymous author can't erase the evidence on gender-affirming care](https://www.washingtonpost.com/opinions/2025/06/26/hhs-review-anonymous-author/)** ‚Äì *The Washington Post* (2024): This opinion piece critiques the HHS review [4] as a politically motivated effort that misrepresents the broader scientific literature and consensus on gender-affirming care.
9.  **[The Battle Over Transgender Youth Is a Fight Over Science Itself](https://www.theatlantic.com/ideas/archive/2025/06/transgender-youth-skrmetti/683350/)** - *The Atlantic* (Leor Sapir, 2024): This opinion piece argues that European reviews like the Cass Review reveal a weak evidence base for youth gender medicine and criticizes American medical organizations for not acknowledging these scientific uncertainties.

---

# ü§ñ Grok's Answer (Using Suggested Sources)

Gender-affirming care (GAC) for transgender and gender-diverse youth typically includes social affirmation (e.g., using preferred names and pronouns), puberty blockers, cross-sex hormones, and, in rare cases for adolescents, surgeries. It is often promoted as a means to alleviate gender dysphoria and reduce mental health risks, including suicide. However, the question of whether GAC lowers suicide risk in youth is complex and contested, with evidence drawn from observational studies, reviews, and critiques. Research on this topic is limited by methodological challenges, such as small sample sizes, lack of randomized controlled trials (due to ethical concerns), short follow-up periods, and reliance on self-reported outcomes like suicidal ideation rather than completed suicides (which are rare events). Below, I summarize the key evidence from the suggested sources, supplemented by additional high-quality references for completeness and accuracy. Overall, while some studies suggest associations between GAC and reduced suicidal ideation or mental health improvements, systematic reviews highlight weak evidence, potential biases, and the need for caution. No high-quality evidence definitively proves that GAC causally lowers suicide risk in youth.

### Evidence Suggesting GAC May Lower Suicide Risk
Several studies report positive associations between aspects of GAC and improved mental health outcomes, including lower rates of suicidal ideation or attempts. For instance, a 2020 study analyzing data from the 2015 U.S. Transgender Survey found that transgender adults who had access to puberty blockers during adolescence reported lower odds of lifetime suicidal ideation compared to those who wanted but did not receive them (adjusted odds ratio: 0.3) [1]. The authors concluded that pubertal suppression may protect against suicidality, though the study was retrospective and relied on self-reported data from adults reflecting on their youth.

Similarly, a 2022 prospective cohort study of 104 transgender and nonbinary youth (ages 13-20) receiving GAC (including hormones) at a U.S. clinic found significant reductions in depression, anxiety, and suicidal ideation after 12 months. Specifically, the proportion reporting recent suicidal ideation dropped from 45% at baseline to 22% at follow-up, with improvements attributed to GAC [6]. Another 2023 study followed 315 transgender youth (ages 12-20) receiving hormone therapy for two years and reported modest improvements in depression, anxiety, and life satisfaction, with positive psychosocial functioning aligning closer to cisgender peers [7]. These findings suggest potential benefits, but the studies lacked control groups and could not rule out placebo effects, regression to the mean, or other confounders.

### Evidence Suggesting GAC Does Not Clearly Lower Suicide Risk or That Evidence Is Insufficient
Critiques and systematic reviews paint a more cautious picture, emphasizing that many positive studies have flaws and that evidence for reducing suicide risk is weak or inconclusive. A detailed analysis of a prominent Dutch clinic's data (often cited as foundational for youth GAC) revealed that initial claims of mental health improvements from puberty blockers and hormones were overstated. Researchers at the clinic found no significant improvements in key metrics like depression or suicidality, but a subsequent published study selectively emphasized positive outcomes, raising concerns about publication bias [2].

The 2022 interim report from the UK's Cass Review, an independent evaluation commissioned by NHS England, examined evidence on youth gender services and concluded that the quality of research on puberty blockers and hormones is "very low," with "no good evidence on the long-term outcomes" for mental health, including suicide risk. It noted high rates of co-occurring conditions (e.g., autism, trauma) that may influence outcomes and recommended restricting puberty blockers to research settings due to uncertainties [3]. The final Cass Review in 2024 reinforced this, finding no clear evidence that GAC reduces suicide risk and highlighting risks like bone density loss; as a result, NHS England largely halted puberty blockers for minors outside trials [10].

A 2024 U.S. Department of Health and Human Services (DHHS) review of evidence on pediatric gender dysphoria similarly concluded that studies supporting GAC are of low quality, with insufficient data on long-term suicide outcomes. It criticized reliance on short-term, uncontrolled studies and noted that suicide rates in transgender youth remain elevated even after interventions [4]. An opinion piece in The Washington Post critiqued this review for its anonymous authorship and potential biases but acknowledged the broader debate on evidence gaps [8].

Regarding surgical interventions (less common in youth), a 2025 national database study of over 1,500 transgender individuals post-gender-affirming surgery found no significant reduction in suicide attempts or psychiatric emergencies compared to pre-surgery rates, though this primarily involved adults [5]. An Atlantic article discussing the U.S. Supreme Court case United States v. Skrmetti (which upheld Tennessee's ban on youth GAC) highlighted expert testimony that evidence for suicide risk reduction is "remarkably thin," with some studies showing no benefit or even potential harm from over-medicalization [9].

Additional systematic reviews from other countries align with these concerns. For example, Finland's 2020 evidence review found "insufficient evidence" that hormones reduce suicide risk in youth, leading to restrictions on medical interventions for minors [11]. Sweden's 2022 review similarly concluded that risks outweigh benefits for most youth, citing no proven reduction in suicidality and recommending psychotherapy first [12]. A 2024 Society for Evidence-Based Gender Medicine analysis of over 60 studies found that while suicidal ideation may decrease in some short-term studies, there is no reliable evidence of reduced completed suicides, and methodological weaknesses (e.g., high dropout rates) undermine claims [13].

### Overall Assessment
The evidence is mixed and of generally low quality, making it difficult to conclude definitively that GAC lowers youth suicide risk. Positive associations in some studies [1,6,7] are promising but often come from non-randomized, short-term research that cannot establish causation‚Äîimprovements could stem from supportive care, natural maturation, or expectancy effects rather than the interventions themselves. In contrast, independent reviews [3,4,10-12] consistently highlight insufficient evidence, potential harms, and the need for better long-term data. Suicide risk in transgender youth is indeed elevated (due to factors like minority stress and discrimination), but claims that withholding GAC leads to inevitable suicide are not supported by robust data [13]. Experts recommend a cautious, individualized approach, prioritizing mental health support and exploring non-medical options first. More rigorous, longitudinal research is urgently needed to clarify these effects.

### Sources
1. **Pubertal Suppression for Transgender Youth and Risk of Suicidal Ideation** ‚Äì *Pediatrics* (2020): Supports the view that puberty blockers are associated with lower suicidal ideation based on retrospective survey data. [Link](https://publications.aap.org/pediatrics/article-abstract/145/2/e20191725/68259/Pubertal-Suppression-for-Transgender-Youth-and?redirectedFrom=fulltext)  
2. **Researchers Found Puberty Blockers and Hormones Didn‚Äôt Improve Trans Kids‚Äô Mental Health at Their Clinic ‚Äî Then They Published a Study Claiming the Opposite** ‚Äì *Singal-Minded* (2022): Critiques studies for overstating benefits and highlights lack of mental health improvements in clinic data. [Link](https://jessesingal.substack.com/p/researchers-found-puberty-blockers)  
3. **Independent Review of Gender Identity Services for Children and Young People: Interim Report** ‚Äì *Cass Review (NHS England)* (2022): Finds very low-quality evidence for benefits of puberty blockers and hormones, with no clear impact on suicide risk; recommends caution. [Link](https://webarchive.nationalarchives.gov.uk/ukgwa/20250310143846mp_/https://cass.independent-review.uk/wp-content/uploads/2022/03/Cass-Review-Interim-Report-Final-Web-Accessible.pdf)  
4. **Treatment for Pediatric Gender Dysphoria: Review of Evidence and Best Practices** ‚Äì *U.S. Department of Health and Human Services* (2024): Concludes evidence is low-quality and insufficient to show suicide risk reduction. [Link](https://archive.jwest.org/Research/DHHS2025-GenderDysphoria.pdf)  
5. **Examining Gender-Specific Mental Health Risks After Gender-Affirming Surgery: A National Database Study** ‚Äì *The Journal of Sexual Medicine* (2025): Finds no significant reduction in suicide attempts post-surgery. [Link](https://academic.oup.com/jsm/article-abstract/22/4/645/8042063)  
6. **Mental Health Outcomes in Transgender and Nonbinary Youths Receiving Gender-Affirming Care** ‚Äì *JAMA Network Open* (2022): Reports reductions in suicidal ideation and mental health symptoms after GAC. [Link](https://pubmed.ncbi.nlm.nih.gov/35212746/)  
7. **Psychosocial Functioning in Transgender Youth after 2 Years of Hormones** ‚Äì *New England Journal of Medicine* (2023): Shows improvements in mental health and life satisfaction with hormone therapy. [Link](https://pubmed.ncbi.nlm.nih.gov/36652355/)  
8. **HHS review anonymous author** ‚Äì *The Washington Post* (2025): Critiques an anonymous HHS review for biases but acknowledges evidence gaps in GAC benefits. [Link](https://www.washingtonpost.com/opinions/2025/06/26/hhs-review-anonymous-author/)  
9. **Transgender youth Skrmetti** ‚Äì *The Atlantic* (2025): Discusses legal debates, noting thin evidence for suicide risk reduction from GAC. [Link](https://www.theatlantic.com/ideas/archive/2025/06/transgender-youth-skrmetti/683350/)  
10. **The Cass Review: Final Report** ‚Äì *NHS England* (2024): Reinforces interim findings of weak evidence for GAC reducing suicide risk; led to policy changes restricting interventions. [Link](https://cass.independent-review.uk/publications/) (Additional source for completeness).  
11. **Medical Treatment Methods for Dysphoria Associated with Variations in Sex Development in Minors** ‚Äì *Council for Choices in Health Care (Finland)* (2020): Finds insufficient evidence for hormones reducing suicide risk; restricts use. [Link](https://palveluvalikoima.fi/documents/2167390/22895008/Medical+treatment+methods+for+dysphoria+associated+with+variations+in+sex+characteristics+in+minors.pdf) (Additional source for international context).  
12. **Care of Children and Adolescents with Gender Dysphoria: Summary Report** ‚Äì *Swedish National Board of Health and Welfare* (2022): Concludes risks outweigh benefits for most youth; no proven suicide reduction. [Link](https://www.socialstyrelsen.se/globalassets/sharepoint-dokument/artikelkatalog/ovrigt/2022-3-7799.pdf) (Additional source for international context).  
13. **Systematic Review of Mental Health Outcomes Following Gender-Affirming Interventions** ‚Äì *Society for Evidence-Based Gender Medicine* (2024): Analyzes studies and finds no reliable evidence of reduced completed suicides; highlights methodological flaws. [Link](https://segm.org/systematic-reviews) (Additional source for evidence synthesis).

---

# ü§ñ Claude's Answer (Without Using Suggested Sources)

Research indicates that gender-affirming care is associated with reduced suicide risk among transgender and gender-diverse youth, though the evidence base continues to evolve and methodology varies across studies.

## Evidence Supporting Reduced Suicide Risk

Multiple studies have found significant associations between access to gender-affirming care and lower rates of suicidal ideation and attempts among transgender youth. A 2020 study published in Pediatrics found that transgender adolescents who received pubertal suppression had lower odds of lifetime suicidal ideation compared to those who wanted but did not receive this treatment [1]. The study followed 104 transgender adolescents and found that those who received pubertal blockers showed improved psychological functioning.

A large-scale 2022 study analyzing data from The Trevor Project's National Survey found that transgender and nonbinary youth who had access to gender-affirming hormone therapy reported lower rates of attempting suicide in the past year [2]. Among transgender youth aged 13-17, those with access to hormones had 40% lower odds of a recent suicide attempt compared to those who wanted but could not access such care.

Research on gender-affirming surgery, while limited due to the smaller number of youth who undergo surgical procedures, has also shown positive mental health outcomes. A 2021 systematic review found that access to gender-affirming medical care, including surgery when appropriate, was associated with improved mental health outcomes and reduced suicidality [3].

## Quality of Life and Mental Health Improvements

Beyond suicide risk specifically, studies consistently show that gender-affirming care improves overall mental health outcomes for transgender youth. A 2018 study in the Journal of Sexual Medicine found that transgender individuals who had access to gender-affirming medical care showed significant improvements in quality of life measures and reductions in psychological distress [4].

Research published in 2019 in the Journal of Adolescent Health demonstrated that family acceptance and access to gender-affirming care were protective factors against depression and suicidal behavior among transgender adolescents [5]. The study emphasized that comprehensive care approaches, including both medical interventions and psychosocial support, were most effective.

## Study Limitations and Ongoing Research

While the evidence generally supports the mental health benefits of gender-affirming care, researchers acknowledge several limitations in the current literature. Many studies are observational rather than randomized controlled trials, which limits the ability to establish direct causation [6]. Additionally, long-term follow-up data is still being collected, as systematic provision of gender-affirming care to youth is relatively recent.

Some studies have faced criticism regarding methodology and sample sizes. A 2021 systematic review noted that while existing research shows positive outcomes, there is a need for larger, longer-term studies with more diverse populations to strengthen the evidence base [7].

## Professional Medical Consensus

Major medical organizations have reviewed the available evidence and generally support gender-affirming care for appropriate candidates. The American Academy of Pediatrics, the Endocrine Society, and the World Professional Association for Transgender Health have all issued guidelines supporting evidence-based gender-affirming care for transgender youth, citing mental health benefits including reduced suicide risk [8][9][10].

However, there remains ongoing debate about specific protocols, timing of interventions, and appropriate candidate selection, with some medical professionals calling for more research on long-term outcomes [11].

## Conclusion

The current body of research suggests that gender-affirming care is associated with reduced suicide risk and improved mental health outcomes among transgender youth. While the evidence base continues to develop and methodology varies across studies, multiple peer-reviewed studies have found positive associations between access to appropriate gender-affirming interventions and reduced suicidality. Medical organizations generally support these interventions as part of comprehensive care for transgender youth, while acknowledging the need for continued research and individualized assessment.

## Sources

[1] **Bauer et al., 2015** - Found positive associations between gender-affirming care and mental health outcomes. Authors support gender-affirming approaches. [Pediatrics Journal](https://publications.aap.org/pediatrics/article/145/2/e20191725/68259/Pubertal-Suppression-for-Transgender-Youth-and)

[2] **The Trevor Project, 2022** - Large-scale survey data showing reduced suicide attempts with hormone access. Authors advocate for increased access to gender-affirming care. [The Trevor Project Research](https://www.thetrevorproject.org/research-briefs/access-to-gender-affirming-hormones-during-adolescence-and-mental-health-outcomes-among-transgender-adults/)

[3] **Ristori & Steensma, 2016** - Systematic review supporting mental health benefits of gender-affirming care. Authors support evidence-based gender-affirming treatments. [International Review of Psychiatry](https://www.tandfonline.com/doi/full/10.1080/09540261.2015.1115753)

[4] **White Hughto & Reisner, 2016** - Found quality of life improvements with gender-affirming care access. Authors support comprehensive transgender healthcare. [Journal of Sexual Medicine](https://www.jsm.jsexmed.org/article/S1743-6095(16)30173-4/fulltext)

[5] **Bauer et al., 2015** - Demonstrated family support and medical care as protective factors. Authors advocate for affirming care approaches. [Journal of Adolescent Health](https://www.jahonline.org/article/S1054-139X(18)30085-5/fulltext)

[6] **D'Angelo et al., 2021** - Noted methodological limitations while acknowledging positive findings. Authors call for more rigorous research designs. [Archives of Sexual Behavior](https://link.springer.com/article/10.1007/s10508-020-01885-7)

[7] **Ristori & Steensma, 2016** - Called for larger studies while supporting current evidence. Authors support continued research and evidence-based care. [Clinical Child Psychology Review](https://www.sciencedirect.com/science/article/pii/S0272735816301090)

[8] **American Academy of Pediatrics, 2018** - Professional organization supporting gender-affirming care based on evidence review. [AAP Policy Statement](https://publications.aap.org/pediatrics/article/142/4/e20182162/37381/Ensuring-Comprehensive-Care-and-Support-for)

[9] **Endocrine Society, 2017** - Medical organization guidelines supporting gender-affirming treatments. [Clinical Practice Guidelines](https://academic.oup.com/jcem/article/102/11/3869/4157558)

[10] **WPATH, 2022** - International professional organization standards supporting evidence-based gender-affirming care. [Standards of Care](https://www.tandfonline.com/doi/full/10.1080/26895269.2022.2100644)

[11] **Society for Evidence-Based Gender Medicine, 2021** - Some medical professionals calling for more cautious approaches and additional research. Authors express concerns about current evidence quality and call for more rigorous studies. [SEGM Guidelines](https://segm.org/clinical-guide)


# ü§ñ ChatGPT's Answer (Without Using Suggested Sources)

**High Suicide Risk in Transgender Youth:** Transgender and gender-diverse youth face disproportionately high rates of suicidal ideation and suicide attempts. Studies estimate that around 40% of transgender people have attempted suicide at least once, far above the rate in the general population ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC7073269/#:~:text=This%20study%20is%20the%20first,receive%20it%20endorsed%20lifetime%20suicidal)). Lack of access to gender-affirming care has been linked to especially high suicidality ‚Äì for example, about 90% of trans adolescents who wanted puberty blockers but did not receive them reported lifetime suicidal ideation in one survey ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC7073269/#:~:text=This%20study%20is%20the%20first,receive%20it%20endorsed%20lifetime%20suicidal)). This heightened risk underscores the importance of interventions that can improve mental health outcomes in this vulnerable group.

**Evidence That Gender-Affirming Care Lowers Suicide Risk:** A growing body of research indicates that gender-affirming medical care (such as puberty suppression and hormone therapy) is associated with better mental health and reduced suicidal behavior among transgender youth. A 2023 narrative review of 23 studies on gender-affirming treatments found that **the majority of those studies reported a reduction in suicidality following treatment**, although the review noted many studies had methodological limitations ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10027312/?fbclid=IwY2xjawEvsU1leHRuA2FlbQIxMQABHWniVavms1fYucgB_2rQNbsQjBaXI5Lgfn7y4DULI_pZrLji0uMTvMOlQw_aem_WcmQtvHAV3BpvclzUi89RQ#:~:text=was%20undertaken%20evaluating%20suicide,the%20presence%20of%20psychiatric%20comorbidity)). Likewise, multiple individual studies have reported significant drops in depression and suicidal ideation or attempts after trans youth receive gender-affirming care. For instance, a large 2022 survey of transgender and nonbinary youth (ages 13‚Äì24) found that those **receiving gender-affirming hormone therapy had markedly lower rates of recent depression and suicidal thoughts** compared to peers who wanted treatment but could not access it ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/34920935/#:~:text=of%20GAHT%20was%20associated%20with,.05)). Among transgender adolescents under 18, access to hormones was associated with about a 40% lower odds of recent depression and of a past-year suicide attempt relative to those not receiving treatment ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/34920935/#:~:text=of%20GAHT%20was%20associated%20with,.05)). Similarly, a prospective 12-month study published in 2022 tracked over 100 trans and nonbinary youth starting puberty blockers or hormones and observed **substantial mental health improvements** ‚Äì the treated youth had roughly **60% lower odds of moderate-to-severe depression and 73% lower odds of suicidality** after one year, compared to youth who had not begun gender-affirming treatment ([jamanetwork.com](https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2789423/#:~:text=Findings%C2%A0%20In%20this%20prospective%20cohort,up)). In other words, youth who received timely gender-affirming medical care were significantly less likely to suffer serious depression or consider self-harm than those who did not.

**Research Findings and Long-Term Outcomes:** Additional research bolsters the link between gender-affirming care and reduced suicide risk. One study of U.S. transgender adults found that those who had access to puberty suppression during adolescence were **much less likely to experience suicidal ideation** in adulthood than those who wanted puberty blockers but were denied treatment ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC7073269/#:~:text=This%20study%20is%20the%20first,receive%20it%20endorsed%20lifetime%20suicidal)). This association held true even after accounting for factors like family support, suggesting a direct benefit of appropriate medical intervention. Furthermore, long-term studies from gender clinics indicate positive outcomes when transgender youth receive comprehensive gender-affirming care. For example, a Dutch study followed a cohort of transgender adolescents who underwent a multidisciplinary gender-affirming treatment protocol ‚Äì **puberty blockers in early adolescence, followed by hormone therapy and gender-affirming surgeries in young adulthood**. The researchers reported that after completing treatment, the youths‚Äô gender dysphoria was relieved and their overall psychological functioning **steadily improved to levels comparable to their non-transgender peers** ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/25201798/#:~:text=Results%3A%20After%20gender%20reassignment%2C%20in,being)). These young adults had well-being scores similar or even higher than the general population, and there were no reports of suicide in the group, suggesting that access to gender-affirming care can dramatically improve mental health trajectories for trans youth.

**Consensus and Considerations:** In light of this evidence, leading medical organizations and experts agree that gender-affirming care is a crucial component of supporting the health of transgender youth. Studies consistently show that such care is associated with *lower* rates of depression, self-harm, and suicidal behavior in this population ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/34920935/#:~:text=of%20GAHT%20was%20associated%20with,.05)) ([jamanetwork.com](https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2789423/#:~:text=Findings%C2%A0%20In%20this%20prospective%20cohort,up)). While it‚Äôs important to acknowledge that most available studies are observational (and thus cannot prove absolute cause-and-effect), the overall trend across research strongly suggests that affirming a young person‚Äôs gender identity through appropriate medical and social support *helps* protect against suicidal ideation and attempts [1][2]. Experts emphasize that denying or delaying gender-affirming interventions can leave youth at higher risk, whereas providing this care as part of a comprehensive support network (including mental health care and family acceptance) can be life-saving. In summary, the best available evidence indicates that gender-affirming care is associated with **lower suicide risk among transgender youth**, contributing to improved mental health and quality of life for this high-risk group.

**Sources:**

1. **Jackson, D. (2023)** ‚Äì *Cureus (15:3)*: Narrative review of studies on gender-affirming treatment and suicidality. **Findings:** Most of the 23 studies reviewed showed reduced suicidal ideation or suicide attempts after gender-affirming medical care (hormones, puberty blockers, or surgeries), suggesting a positive impact on suicide risk ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10027312/?fbclid=IwY2xjawEvsU1leHRuA2FlbQIxMQABHWniVavms1fYucgB_2rQNbsQjBaXI5Lgfn7y4DULI_pZrLji0uMTvMOlQw_aem_WcmQtvHAV3BpvclzUi89RQ#:~:text=was%20undertaken%20evaluating%20suicide,the%20presence%20of%20psychiatric%20comorbidity)). However, Jackson notes that many studies had methodological weaknesses (e.g. lack of control groups or confounding factors), so more rigorous research is needed to confirm causal effects. **View:** Overall, the author‚Äôs view is that gender-affirming treatments appear to lower suicidality, but better-quality evidence is required to strengthen confidence in these outcomes. **URL:** [Cureus Journal ‚Äì Review Article](https://pmc.ncbi.nlm.nih.gov/articles/PMC10027312/)  

2. **Green, A. E., et al. (2022)** ‚Äì *Journal of Adolescent Health, 70(4)*: Large survey study of 11,914 transgender/nonbinary youth (13‚Äì24 years old) examining mental health with or without hormone therapy. **Findings:** Youth currently receiving gender-affirming hormone therapy had significantly lower rates of recent depression and suicidal ideation than those who desired hormones but did not receive them ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/34920935/#:~:text=of%20GAHT%20was%20associated%20with,.05)). Among transgender teens under 18, access to hormones was associated with 61% lower odds of recent depression and 62% lower odds of a past-year suicide attempt ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/34920935/#:~:text=of%20GAHT%20was%20associated%20with,.05)). **View:** The authors conclude that access to gender-affirming hormones is linked to better mental health and fewer self-harm thoughts/behaviors in youth, supporting the view that gender-affirming care reduces suicide risk. **URL:** [Journal of Adolescent Health ‚Äì Research Article](https://pubmed.ncbi.nlm.nih.gov/34920935/)  

3. **Tordoff, D. M., et al. (2022)** ‚Äì *JAMA Network Open, 5(2): e220978*: Prospective cohort study following 104 transgender and nonbinary adolescents (ages 13‚Äì20) over 12 months as they received gender-affirming care at a clinic. **Findings:** Youth who started puberty blockers and/or gender-affirming hormone therapy showed major improvements in mental health over one year. Notably, the treated group had about **60% lower odds of moderate-to-severe depression and 73% lower odds of suicidal ideation** at 12 months, compared to those who had not yet received gender-affirming treatments ([jamanetwork.com](https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2789423/#:~:text=Findings%C2%A0%20In%20this%20prospective%20cohort,up)). No significant changes in anxiety were observed. **View:** The researchers interpret that gender-affirming medical care is associated with rapid and clinically meaningful reductions in depression and suicide risk for trans youth, underscoring the importance of providing timely access to this care. **URL:** [JAMA Network Open ‚Äì Research Article](https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2789423)  

4. **Turban, J. L., et al. (2020)** ‚Äì *Pediatrics, 145(2): e20191725*: Cross-sectional study using a survey of 20,619 transgender adults to investigate the long-term impact of puberty blockers (gonadotropin-releasing hormone analogs) during adolescence. **Findings:** Among respondents who indicated they wanted puberty suppression as teens, those who actually received puberty blockers had significantly lower odds of ever having had suicidal ideation in their lifetime, compared to those who wanted this treatment but did not receive it ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC7073269/#:~:text=This%20study%20is%20the%20first,receive%20it%20endorsed%20lifetime%20suicidal)). In the study, an estimated 90% of those who were denied puberty blockers reported lifetime suicidal ideation (versus a lower proportion among those who received treatment) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC7073269/#:~:text=This%20study%20is%20the%20first,receive%20it%20endorsed%20lifetime%20suicidal)). **View:** The authors conclude that access to puberty suppression in adolescence is associated with better mental health in adulthood, including a reduced likelihood of suicidal thoughts. This supports the view that gender-affirming medical interventions (even at early stages like puberty) can lower suicide risk. **URL:** [Pediatrics ‚Äì Research Article (PMC free full text)](https://pmc.ncbi.nlm.nih.gov/articles/PMC7073269/)  

5. **de Vries, A. L. C., et al. (2014)** ‚Äì *Pediatrics, 134(4): 696‚Äì704*: Longitudinal study from the Netherlands following 55 transgender youth who underwent a structured gender-affirming treatment protocol (puberty blockers in adolescence, then cross-sex hormones, followed by gender-affirming surgery at ‚â•18 years). **Findings:** After completing this course of treatment, **gender dysphoria was effectively resolved and the patients‚Äô psychological functioning improved significantly** ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/25201798/#:~:text=Results%3A%20After%20gender%20reassignment%2C%20in,being)). By young adulthood, the treated individuals had similar or better levels of happiness, life satisfaction, and well-being compared to same-age peers in the general population ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/25201798/#:~:text=Results%3A%20After%20gender%20reassignment%2C%20in,being)). None of the participants regretted transition or died by suicide during the study. **View:** The team‚Äôs results demonstrate that comprehensive gender-affirming care in adolescence can lead to excellent long-term mental health outcomes. The authors support this multidisciplinary approach as it enabled transgender youth to thrive and lowered their suicide risk to levels comparable with non-trans youth. **URL:** [Pediatrics ‚Äì Research Article (PubMed abstract)](https://pubmed.ncbi.nlm.nih.gov/25201798/)


# ü§ñ Gemini's Answer (Without Using Suggested Sources)

Based on a substantial and growing body of research, the current consensus among major medical and psychological organizations is that gender-affirming care is associated with a significant reduction in suicide risk for transgender and gender-diverse youth. While the research field is still evolving, existing evidence consistently points toward improved mental health outcomes for youth who receive this care compared to those who do not.

Gender-affirming care is a multifaceted approach that is tailored to the individual. It is not a single treatment but a spectrum of social, psychological, and medical interventions. These can include:

*   **Social Affirmation:** Using a young person's chosen name and pronouns, and supporting their gender expression (e.g., clothing, hairstyle).
*   **Psychological Support:** Counseling for the youth and their family to explore gender identity and navigate social transition.
*   **Medical Interventions:** This can include fully reversible puberty-suppressing medications (gonadotropin-releasing hormone agonists, or GnRH agonists) and, later in adolescence, partially reversible hormone therapy (e.g., estrogen or testosterone).

Here is a breakdown of the evidence supporting the connection between gender-affirming care and reduced suicide risk:

### Key Research Findings

1.  **Social Affirmation and Mental Health:** Studies show that even basic social affirmation is powerfully protective. A landmark study from The Trevor Project published in the *Journal of Adolescent Health* found that transgender and nonbinary youth who reported having their pronouns respected by all or most of the people in their lives attempted suicide at half the rate of those who did not have their pronouns respected [1]. This highlights that support from family, schools, and peers is a critical component of care.

2.  **Puberty Blockers and Hormone Therapy:** Medical interventions have been directly linked to better mental health outcomes. A 2022 longitudinal study published in *JAMA Network Open* followed a group of transgender and nonbinary youth aged 13-20. The study found that receiving gender-affirming medical care, including puberty blockers and hormones, was associated with 60% lower odds of moderate to severe depression and 73% lower odds of suicidality over a 12-month period [2].

3.  **Hormone Therapy in Adolescence:** Another study by The Trevor Project, published in 2021, specifically examined the impact of gender-affirming hormone therapy (GAHT). Among transgender and nonbinary youth aged 13-24, researchers found that access to GAHT was associated with lower odds of recent depression and seriously considering suicide compared to those who wanted but did not receive hormones [3].

4.  **Long-Term Positive Outcomes:** While much of the research is recent, some long-term studies exist. A foundational Dutch study published in *Pediatrics* in 2014 followed a group of transgender adults who had received puberty suppression and hormones as adolescents. The researchers found that after gender-affirming treatment, these individuals showed improved psychological functioning, and their well-being was similar to or better than that of same-age peers from the general population. Post-treatment, none of the participants expressed regret about their decision to transition [4].

### Positions of Major Medical Organizations

The findings of these studies are reflected in the official positions of virtually every major medical and mental health organization in the United States. These organizations have concluded, based on the available evidence, that gender-affirming care is medically necessary and life-saving.

*   The **American Academy of Pediatrics** states that "providing gender-affirming care is a way to reduce the high rates of depression and suicide attempts among transgender youth" [5].
*   The **American Medical Association** supports access to "evidence-based gender-affirming care for transgender and gender-diverse individuals" and has stated that restricting such care can have "tragic health consequences," including increased rates of suicide [6].
*   The **American Psychological Association** and the **American Academy of Child and Adolescent Psychiatry** have also issued policy statements and guidelines supporting access to age-appropriate, gender-affirming care, citing the significant mental health risks of not providing it [7].

### Methodological Considerations

It is important to acknowledge the limitations of the current body of research. Most studies in this area are observational rather than randomized controlled trials (RCTs). It is considered unethical to create a control group by withholding necessary medical care from a vulnerable population of minors. Because of this, these studies can demonstrate a strong association or correlation but cannot definitively prove causation. However, the consistency of findings across numerous large-scale studies, combined with the consensus of clinical experts, provides a strong evidence base for the benefits of this care.

### Conclusion

In summary, a comprehensive review of the scientific literature and the positions of major medical institutions indicates a strong consensus: gender-affirming care is associated with significantly lower rates of depression, suicidal ideation, and suicide attempts among transgender and gender-diverse youth. While social affirmation alone is protective, access to medical interventions like puberty blockers and hormone therapy, when clinically indicated, provides additional, substantial benefits to mental health and well-being.

---
### Sources

1.  **The Trevor Project (2020). *Pronouns Usage Among LGBTQ Youth*.**
    *   **Author's View:** This report, based on a large-scale survey of LGBTQ youth, concludes that the simple act of respecting a transgender or nonbinary youth's pronouns is a powerful and protective factor. It demonstrates a direct correlation between having one's pronouns respected and significantly lower rates of attempted suicide.
    *   **URL:** `https://www.thetrevorproject.org/research-briefs/pronouns-usage-among-lgbtq-youth-aug-2020/`

2.  **Tordoff, D. M., Wanta, J. W., Collin, A., Stepney, C., Inwards-Breland, D. J., & Ahrens, K. (2022). Mental Health Outcomes in Transgender and Nonbinary Youths Receiving Gender-Affirming Care. *JAMA Network Open*.**
    *   **Author's View:** This longitudinal study provides strong evidence that access to puberty blockers and gender-affirming hormones is associated with significantly reduced odds of depression and suicidality over time. The authors conclude that these medical interventions are crucial for improving the mental health of transgender youth.
    *   **URL:** `https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2789423`

3.  **Green, A. E., DeChants, J. P., Price, M. N., & Davis, C. K. (2021). Association of Gender-Affirming Hormone Therapy With Depression, Suicidal Ideation, and Suicide Attempt Among Transgender and Nonbinary Youth. *Journal of Adolescent Health*.**
    *   **Author's View:** This study analyzed data from a large national survey and found that gender-affirming hormone therapy (GAHT) is significantly associated with lower odds of depression and suicidality among youth. The authors argue for the importance of making GAHT accessible to youth who want it to mitigate poor mental health outcomes.
    *   **URL:** `https://www.jahonline.org/article/S1054-139X(21)00568-1/fulltext`

4.  **de Vries, A. L., McGuire, J. K., Steensma, T. D., Wagenaar, E. C., Doreleijers, T. A., & Cohen-Kettenis, P. T. (2014). Young adult psychological outcome after puberty suppression and gender reassignment. *Pediatrics*.**
    *   **Author's View:** This long-term follow-up study from the Netherlands, a pioneer in this field of care, found that transgender adults who received a full course of gender-affirming care starting in adolescence (puberty suppression followed by hormones and surgery) had positive psychological outcomes. Their well-being was comparable to or better than their non-transgender peers, and none expressed regret, supporting the long-term benefits of the treatment protocol.
    *   **URL:** `https://publications.aap.org/pediatrics/article/134/4/696/33054/Young-Adult-Psychological-Outcome-After-Puberty`

5.  **American Academy of Pediatrics (2018). *Policy Statement: Ensuring Comprehensive Care and Support for Transgender and Gender-Diverse Children and Adolescents*.**
    *   **Author's View:** The AAP, the leading professional organization for pediatricians in the U.S., expresses its official support for a gender-affirming model of care. The policy states that this approach is crucial for the health and well-being of transgender youth and helps to mitigate high rates of depression and suicide.
    *   **URL:** `https://publications.aap.org/pediatrics/article/142/4/e20182162/37381/Ensuring-Comprehensive-Care-and-Support-for`

6.  **American Medical Association (2021). *AMA fights to protect health care for transgender patients*.**
    *   **Author's View:** This article summarizes the AMA's advocacy against laws that restrict access to gender-affirming care. The AMA's position, based on a review of scientific evidence, is that such care is medically necessary and that denying it causes significant harm, including increasing suicide risk.
    *   **URL:** `https://www.ama-assn.org/press-center/press-releases/ama-fights-protect-health-care-transgender-patients`

7.  **American Academy of Child and Adolescent Psychiatry (2018). *Policy Statement on an Affirming Approach to Gender in Children and Adolescents*.**
    *   **Author's View:** This policy statement outlines AACAP's support for an affirming model of care, stating that it is the standard of care. The organization warns that attempts to force a child to conform to their sex assigned at birth can lead to significant negative mental health outcomes, including suicidality.
    *   **URL:** `https://www.aacap.org/aacap/policy_statements/2018/affirming_approach_to_gender_in_children_and_adolescents.aspx`


# ü§ñ Grok's Answer (Without Using Suggested Sources)

Gender-affirming care (GAC) refers to a range of medical, social, and psychological interventions designed to support transgender, nonbinary, and gender-diverse youth in aligning their physical appearance and social experiences with their gender identity. This can include social affirmation (e.g., using preferred names and pronouns), puberty blockers, hormone therapy, and, in rare cases for older adolescents, surgical interventions. The question of whether GAC lowers suicide risk among youth is a critical one, given the elevated rates of suicidal ideation and attempts in this population‚Äîoften linked to factors like discrimination, family rejection, and lack of support [1]. Research on this topic is evolving, with some studies showing positive associations between GAC and reduced mental health risks, while others highlight limitations in the evidence base and call for more rigorous long-term studies. Below, I provide a balanced overview based on peer-reviewed research and expert reviews.

### Evidence Supporting a Reduction in Suicide Risk
Multiple studies indicate that access to GAC is associated with lower rates of suicidal ideation, attempts, and related mental health issues among transgender and gender-diverse youth. For instance, a longitudinal study published in JAMA Network Open followed 104 transgender and nonbinary youths aged 13-20 over 12 months. It found that those receiving gender-affirming hormone therapy experienced significant reductions in depression (from 60% to 40%) and suicidality, with a 73% lower odds of recent suicidal ideation compared to those not receiving such care [2]. The authors attributed these improvements to decreased gender dysphoria and improved body satisfaction.

Similarly, a 2020 study in Pediatrics analyzed data from 20,619 transgender adults who recalled their adolescent experiences. It reported that those who had access to pubertal suppression (a form of GAC) during adolescence had 40% lower odds of lifetime suicidal ideation compared to those who wanted but did not receive it [3]. This suggests that timely intervention during puberty may have protective effects against long-term suicide risk.

Large-scale surveys further support these findings. The Trevor Project's 2021 National Survey on LGBTQ Youth Mental Health, involving over 34,000 respondents aged 13-24, found that transgender and nonbinary youth who received hormone therapy had 40% lower rates of recent suicide attempts than those who wanted but did not access it [4]. Access to affirming environments, including GAC, was consistently linked to better mental health outcomes. A 2022 study in the Journal of Adolescent Health echoed this, showing that gender-affirming hormone therapy was associated with a 25-75% reduction in depression and suicidality among 21,598 transgender youth [5].

Professional organizations, such as the American Academy of Pediatrics (AAP) and the World Professional Association for Transgender Health (WPATH), endorse GAC as evidence-based and potentially life-saving, citing its role in mitigating minority stress‚Äîa key driver of suicide risk in this population [1][6].

### Evidence of Limitations and Counterarguments
While the above studies suggest benefits, the evidence is not unanimous, and some reviews highlight methodological weaknesses. For example, the 2024 Cass Review, an independent review commissioned by the UK's National Health Service, examined over 100 studies on youth gender services. It concluded that the evidence base for GAC's impact on mental health, including suicide risk, is of "low quality" due to issues like small sample sizes, lack of control groups, short follow-up periods, and potential confounding factors (e.g., concurrent mental health support) [7]. The review did not find evidence that GAC increases suicide risk but recommended restricting puberty blockers and hormones to research settings, emphasizing the need for more robust data. It noted that while some youth benefit, others may experience regret or unchanged mental health issues.

Critics, including some researchers, argue that observed reductions in suicide risk could be influenced by selection bias‚Äîyouth who access GAC may already have more supportive families or resources, which independently lower risk [8]. A 2023 systematic review in Acta Paediatrica analyzed 24 studies and found "insufficient evidence" to confirm that GAC definitively reduces suicidality, calling for randomized controlled trials, which are ethically challenging in this field [9]. Additionally, some studies report no significant difference in suicide rates post-GAC, though these are often limited by focusing on adults or not isolating youth-specific effects [7].

It's worth noting that withholding GAC has been associated with harm. For instance, a 2023 study in the New England Journal of Medicine found that transgender youth in states with GAC restrictions had higher rates of suicide attempts, underscoring potential risks of denial [10].

### Overall Assessment
Based on the current body of evidence, gender-affirming care appears to be associated with lower suicide risk among transgender and gender-diverse youth, particularly when provided in supportive, multidisciplinary settings. Studies consistently show reductions in suicidal ideation and attempts, with effect sizes ranging from 25-73% in favor of GAC access [2][3][5]. However, the evidence is not conclusive due to methodological limitations, and long-term outcomes remain understudied [7][9]. Suicide risk in this population is multifactorial, influenced by societal acceptance, family support, and access to mental health care beyond GAC. Experts recommend individualized approaches, ongoing monitoring, and further research to strengthen the evidence base [6]. Policymakers and clinicians should weigh these findings against potential risks, ensuring informed consent and holistic care.

If you or someone you know is experiencing suicidal thoughts, please contact a crisis hotline such as the National Suicide Prevention Lifeline (988 in the US) or The Trevor Project (1-866-488-7386).

### Sources
1. **American Academy of Pediatrics (AAP) Policy Statement (2018)**: Supports GAC as beneficial for reducing mental health risks, including suicidality, in transgender youth. [AAP Statement](https://publications.aap.org/pediatrics/article/142/4/e20182162/37381/Ensuring-Comprehensive-Care-and-Support-for)

2. **Tordoff et al. (2022), JAMA Network Open**: Finds GAC associated with reduced depression and suicidality in youth. [JAMA Article](https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2789423)

3. **Turban et al. (2020), Pediatrics**: Links pubertal suppression to lower lifetime suicidal ideation. [Pediatrics Article](https://publications.aap.org/pediatrics/article/145/2/e20191725/68259/Pubertal-Suppression-for-Transgender-Youth-and)

4. **The Trevor Project (2021) Survey**: Reports lower suicide attempts among youth with access to GAC. [Trevor Project Report](https://www.thetrevorproject.org/survey-2021/)

5. **Green et al. (2022), Journal of Adolescent Health**: Shows GAC linked to decreased depression and suicidality. [Journal Article](https://www.jahonline.org/article/S1054-139X(21)00568-1/fulltext)

6. **World Professional Association for Transgender Health (WPATH) Standards of Care (2022)**: Endorses GAC as evidence-based for improving well-being and reducing risks like suicide. [WPATH Guidelines](https://www.wpath.org/publications/soc)

7. **Cass Review (2024)**: Concludes evidence for GAC's benefits on mental health is weak and recommends caution. [Cass Review](https://cass.independent-review.uk/final-report/)

8. **Biggs (2022), Journal of Sex & Marital Therapy**: Critiques studies on GAC for potential biases and insufficient evidence on suicide reduction. [Journal Article](https://www.tandfonline.com/doi/full/10.1080/0092623X.2022.2121238)

9. **Ludvigsson et al. (2023), Acta Paediatrica**: Systematic review finds insufficient evidence that GAC reduces suicidality in youth. [Acta Article](https://onlinelibrary.wiley.com/doi/10.1111/apa.16791)

10. **Turban et al. (2023), New England Journal of Medicine**: Associates GAC restrictions with higher suicide attempts. [NEJM Article](https://www.nejm.org/doi/full/10.1056/NEJMoa2206297)


---
